Christy Santhosh

4 days ago | itnews.com.au | Puyaan Singh |Christy Santhosh

Health and life insurer Aflac said it is investigating a breach on its US network that may have exposed customers' personal information, making it the latest insurance provider to be targeted in a cyberattack. Aflac said the attack was identified on June 12 and carried out by a sophisticated cybercrime group.

4 days ago | autism.einnews.com | Bhanvi Satija |Christy Santhosh

By Bhanvi Satija and Christy Santhosh(Reuters) -The U.S. Centers for Disease Control and Prevention posted a report on Tuesday that said evidence does not support a link between thimerosal-containing vaccines and autism or other neurodevelopmental disorders, ahead of a two-day meeting of an advisory panel later this week. The report was posted on the agency's website on Tuesday, along with some presentations and the final agenda of the meeting, which is scheduled for June 25 and 26.

1 week ago | azdailysun.com | Puyaan Singh |Christy Santhosh

By Puyaan Singh and Christy Santhosh(Reuters) -Health and life insurer Aflac on Friday said it is investigating a breach on its U.S. network that may have exposed customers' personal information, making it the latest insurance provider to be targeted in a cyberattack. kAmp7=24 D2:5 E96 2EE24< H2D :56?E:7:65 @? yF?6 `a 2?5 42CC:65 @FE 3J 2 D@A9:DE:42E65 4J36C4C:>6 8C@FA]k^AmkAmp? p7=24 DA@<6DA6CD@?

1 week ago | yahoo.com | Puyaan Singh |Christy Santhosh

By Puyaan Singh and Christy Santhosh(Reuters) -Health and life insurer Aflac on Friday said it is investigating a breach on its U.S. network that may have exposed customers' personal information, making it the latest insurance provider to be targeted in a cyberattack. Aflac said the attack was identified on June 12 and carried out by a sophisticated cybercrime group.

1 week ago | jp.reuters.com | Christy Santhosh |Sriparna Roy

６月１７日、米医薬品大手イーライリリーは、遺伝子編集技術の米新興企業バーブ・セラピューティクスを最大１３億ドルで買収し、心血管疾患に対する新たな治療法開発を加速させる方針だ。両社が１７日発表した。写真はイーライリリーのロゴ。２０２３年３月、カリフォルニア州サンディエゴで撮影（２０２５年 ロイター/Mike Blake） [１７日 ロイター] - 米医薬品大手イーライリリー(LLY.N), opens new tabは、遺伝子編集技術の米新興企業バーブ・セラピューティクス(VERV.O), opens new tabを最大１３億ドルで買収し、心血管疾患に対する新たな治療法開発を加速させる方針だ。両社が１７日発表した。 イーライリリーは糖尿病治療薬「マンジャロ」や肥満症治療薬「ゼップバウンド」が業績に大きな追い風となっているが、今回の買収はその先を見据えた成長戦略の一環だ。 両社は既に、一度の遺伝子編集によって心臓病患者の高コレステロールを低下させる治療の開発で提携していた。...